glp 1 causing fatigue This One Mistake Puts GLP-1 Users at Risk of Fatigue, Weakness, and Weight Regain Exploring the Side Effects of
Description
Conclusion Tirzepatide is likely to counteract most of the pathogenetic factors contributing to CKD in T2D, potentially representing a step forward in incretin-based therapy towards nephroprotection
Use of this blog's information is at your own risk
Always involve your prescribing physician in any decision to pause medication
2025;doi:10.2337/dci24-0091
GLP-1 also seem to act on the reward and satiety centers of the brain (more research is being done on exactly what mechanisms)
